Urgent Warning: Weight-Loss Jabs Linked to Unintended Pregnancies

MHRA Issues Urgent Warning to Women on Weight-Loss Injections London, June 5, 2025 – The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a stark warning to women using popular weight-loss injections, urging them to use effective contraception while taking these medications. The warning comes after reports of over 40 pregnancies in women using the drugs, including Wegovy, Ozempic, Saxenda, and Victoza. Of particular concern are 26 cases linked to the drug Mounjaro. "Women taking popular medicines for weight loss and diabetes, sometimes referred to as ‘skinny jabs,’ are being reminded to use effective contraception while taking these medicines," stated an MHRA press release. The agency cites a lack of sufficient safety data as the reason for the urgent advice. The MHRA's advice is unequivocal: women trying to conceive, currently pregnant, or breastfeeding should immediately stop using these medications. Those who continue to use the injections are advised to use additional forms of contraception, such as condoms, to minimize the risk of unintended pregnancy. The agency's announcement highlights the potential risks associated with these widely used medications and underscores the importance of informed decision-making for women considering these treatments. The MHRA continues to monitor the situation and gather data to assess the long-term effects of these drugs on pregnancy and fetal development.